Sonendo Inc SONX

$0.37 -0.91 (-70.96%)

Valuation

Market cap
1,775,000
Revenue TTM
$31,700,000
Net income TTM
$-28,030,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
-88.42%
Debt to equity
2.78

Trading

Volume
100
Avg volume
1,232
Day's range
$0.37 – $0.37
Shares out
4,776,000
Stochastic %K
4%
Beta
1.78
Analysts
—
Price target
$0.25

Price

Company profile

Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and...

Show more

Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for endodontists. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. Sonendo, Inc. was incorporated in 2006 and is headquartered in Laguna Hills, California.

Industry
Medical Devices
Sector
Healthcare
Phone
949 766 3636
Website
https://sonendo.com
Address
26061 Merit Circle, Suite 102, Laguna Hills, United States

Latest news

No headlines yet.